Harlan Waksal - Feb 16, 2022 Form 3 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Signature
/s/ Jason Cavalier, Attorney-in-Fact for Harlan Waksal, M.D.
Stock symbol
LYRA
Transactions as of
Feb 16, 2022
Transactions value $
$0
Form type
3
Date filed
2/18/2022, 04:08 PM
Previous filing
Nov 9, 2021
Next filing
Apr 13, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney.